FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3096548654> ?p ?o ?g. }

• W3096548654 endingPage "799" @default.
• W3096548654 startingPage "789" @default.
• W3096548654 abstract "BRAF inhibitors were approved for the treatment of BRAF-mutant melanoma. However, most patients acquire the resistance to BRAF inhibitors after several months of treatment. miR-524-5p is considered as a tumor suppressor in many cancers, including melanoma. In this study, we investigated the biological functions of miR-524-5p in melanoma with acquired resistance to BRAF inhibitor and evaluated the endogenous miR-524-5p expression as a biomarker for melanoma. The results showed that the expression of miR-524-5p was 0.481-fold lower in melanoma tissues (n = 117) than in nevus tissues (n = 40). Overexpression of miR-524-5p significantly reduced proliferative, anchorage-independent growth, migratory and invasive abilities of BRAF inhibitor-resistant melanoma cells. Moreover, the introduction of miR-524-5p led to a reduced development of BRAF inhibitor-resistant melanoma in vivo. Remarkably, the MAPK/ERK signaling pathway was decreased after treatment with miR-524-5p. Furthermore, next-generation sequencing analysis implied that the complement system, leukocyte extravasation, liver X receptor/retinoid-X-receptor activation, and cAMP-mediated signaling may be related to miR-524-5p-induced pathways in the resistant cells. The miR-524-5p level was higher on average in complete response and long-term partial response patients than in progressive disease and short-term partial response patients treated with BRAF inhibitors. Our results proposed that miR-524-5p could be considered as a target for treatment BRAF inhibitor-resistant melanoma and a prognostic marker in the response of patients to BRAF inhibitors for melanoma." @default.
• W3096548654 created "2020-11-09" @default.
• W3096548654 creator A5002133706 @default.
• W3096548654 creator A5003921294 @default.
• W3096548654 creator A5004693750 @default.
• W3096548654 creator A5005282640 @default.
• W3096548654 creator A5007821279 @default.
• W3096548654 creator A5010626222 @default.
• W3096548654 creator A5014015655 @default.
• W3096548654 creator A5015895902 @default.
• W3096548654 creator A5021881822 @default.
• W3096548654 creator A5032096394 @default.
• W3096548654 creator A5043156508 @default.
• W3096548654 creator A5054628960 @default.
• W3096548654 creator A5074636672 @default.
• W3096548654 creator A5086736499 @default.
• W3096548654 creator A5087317062 @default.
• W3096548654 creator A5087923848 @default.
• W3096548654 date "2020-12-01" @default.
• W3096548654 modified "2023-10-16" @default.
• W3096548654 title "miR-524-5p reduces the progression of the BRAF inhibitor-resistant melanoma" @default.
• W3096548654 cites W1490956705 @default.
• W3096548654 cites W1970845550 @default.
• W3096548654 cites W1971750711 @default.
• W3096548654 cites W1982393730 @default.
• W3096548654 cites W2003402062 @default.
• W3096548654 cites W2009642188 @default.
• W3096548654 cites W2032211985 @default.
• W3096548654 cites W2034031966 @default.
• W3096548654 cites W2043058822 @default.
• W3096548654 cites W2045449074 @default.
• W3096548654 cites W2053473615 @default.
• W3096548654 cites W2065874620 @default.
• W3096548654 cites W2065933951 @default.
• W3096548654 cites W2070230754 @default.
• W3096548654 cites W2100614336 @default.
• W3096548654 cites W2100887597 @default.
• W3096548654 cites W2103557568 @default.
• W3096548654 cites W2105660237 @default.
• W3096548654 cites W2108561242 @default.
• W3096548654 cites W2117937119 @default.
• W3096548654 cites W2127956110 @default.
• W3096548654 cites W2128975886 @default.
• W3096548654 cites W2133717967 @default.
• W3096548654 cites W2141674733 @default.
• W3096548654 cites W2151136040 @default.
• W3096548654 cites W2159220884 @default.
• W3096548654 cites W2166262263 @default.
• W3096548654 cites W2167240074 @default.
• W3096548654 cites W2169198176 @default.
• W3096548654 cites W2176310149 @default.
• W3096548654 cites W2206684187 @default.
• W3096548654 cites W2254578605 @default.
• W3096548654 cites W2337492903 @default.
• W3096548654 cites W2337664219 @default.
• W3096548654 cites W2465561570 @default.
• W3096548654 cites W2500909837 @default.
• W3096548654 cites W2535510152 @default.
• W3096548654 cites W2555143315 @default.
• W3096548654 cites W2568018505 @default.
• W3096548654 cites W2569342357 @default.
• W3096548654 cites W2583315249 @default.
• W3096548654 cites W2592824004 @default.
• W3096548654 cites W2611634061 @default.
• W3096548654 cites W2618175351 @default.
• W3096548654 cites W2756598091 @default.
• W3096548654 cites W2770603707 @default.
• W3096548654 cites W2771436561 @default.
• W3096548654 cites W2773011778 @default.
• W3096548654 cites W2885476476 @default.
• W3096548654 cites W2886720207 @default.
• W3096548654 cites W2891205725 @default.
• W3096548654 cites W2938062190 @default.
• W3096548654 cites W2950011075 @default.
• W3096548654 cites W2950970502 @default.
• W3096548654 cites W3021839250 @default.
• W3096548654 doi "https://doi.org/10.1016/j.neo.2020.10.009" @default.
• W3096548654 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7642759" @default.
• W3096548654 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33142243" @default.
• W3096548654 hasPublicationYear "2020" @default.
• W3096548654 type Work @default.
• W3096548654 sameAs 3096548654 @default.
• W3096548654 citedByCount "9" @default.
• W3096548654 countsByYear W30965486542021 @default.
• W3096548654 countsByYear W30965486542022 @default.
• W3096548654 countsByYear W30965486542023 @default.
• W3096548654 crossrefType "journal-article" @default.
• W3096548654 hasAuthorship W3096548654A5002133706 @default.
• W3096548654 hasAuthorship W3096548654A5003921294 @default.
• W3096548654 hasAuthorship W3096548654A5004693750 @default.
• W3096548654 hasAuthorship W3096548654A5005282640 @default.
• W3096548654 hasAuthorship W3096548654A5007821279 @default.
• W3096548654 hasAuthorship W3096548654A5010626222 @default.
• W3096548654 hasAuthorship W3096548654A5014015655 @default.
• W3096548654 hasAuthorship W3096548654A5015895902 @default.
• W3096548654 hasAuthorship W3096548654A5021881822 @default.
• W3096548654 hasAuthorship W3096548654A5032096394 @default.
• W3096548654 hasAuthorship W3096548654A5043156508 @default.

• next